瑞泊萊醫(yī)藥是一家集研發(fā)、生產(chǎn)、銷(xiāo)售為一體的創(chuàng)新型醫(yī)藥企業(yè)，專(zhuān)注于高活性藥物、抗腫瘤藥物、心腦血管及兒童用藥領(lǐng)域的仿制原料藥、中間體、輔料的開(kāi)發(fā)及生產(chǎn)。 Bioland Pharma is an innovative pharmaceutical company integrating R&D, production and sales of generic APIs, intermediates and excipients, which mainly focuses on high potency, niche products for anti-cancer drugs and pediatric drugs.
公司旗下的生產(chǎn)基地分別通過(guò)了美國(guó)FDA、歐洲EDQM和中國(guó)NMPA審計(jì)或現(xiàn)場(chǎng)核查，多個(gè)產(chǎn)品在國(guó)內(nèi)外成功注冊(cè)，在為客戶提供高質(zhì)量中間體及原料藥產(chǎn)品的同時(shí)，也可以承接原料藥的生產(chǎn)、注冊(cè)MAH外包服務(wù)(CDMO)。Our manufacturing sites have passed the audit or on-site inspection of US FDA, EDQM and China NMPA, respectively. Several of our products have been successfully registered in China and abroad. While supplying customers with high-quality intermediates and APIs, we also provide one-stop CDMO service for our customers.
